retatrutide dosage calculator female dose schedule: complete week-by-week titration guide A Clinician's Guide to Retatrutide

Induction of Epac activity caused the PI3K-dependent Akt phosphorylation, while activation of PKA inhibited Akt activity in HEK-293 cells (Mei et al., 2002)

Sources Lilly investor news Eli Lilly FDA drug approval process FDA.gov Related reading Retatrutide Phase 3 Results 2026: TRIUMPH Trial Tracker Living tracker of every retatrutide trial TRIUMPH-1/2/3/4/5, TRIUMPH-Outcomes, TRANSCEND-T2D-1/2, and SYNERGY-OUTCOMES Phase 3 readouts

Kidney function: Declines 25-30% by age 70 Liver metabolism: Slows 20-40% with aging Total body water: Decreases 10-15% in seniors Muscle mass: Declines 3-8% per decade after 30 Thirst response: Significantly reduced in older adults Clinical Evidence: What the Trials Tell Us About Older Adults Phase 2 clinical trials for Retatrutide included participants up to age 75, providing valuable data on how older adults respond to treatment

- Dosage Options: 40mg / 60mg